
Shukaib Arslan MD
Hematologic Oncology
Assistant Professor, Hematology/HCT
Join to View Full Profile
1500 Duarte RdBradbury, CA 91010
Phone+1 626-256-4673
Dr. Arslan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shukaib Arslan is a specialized healthcare provider in Hematology with a subspecialty in Hematologic Oncology, based in Duarte, CA. He gained comprehensive experience in his field through his education at different medical institutions, including King Edward Medical University and City of Hope National Medical Center, where he completed a fellowship in Blood & Bone Marrow Transplant. He is currently serving as an Assistant Clinical Professor at City of Hope. Dr. Arslan has contributed a variety of scholarly articles to the medical field, indicating his active participation in research. His work is published in notable journals such as Transplantation and Cellular Therapy, Cureus, and Cancer Medicine.
Education & Training
City of Hope National Medical CenterFellowship, Blood & Bone Marrow Transplant, 2018 - 2019
Ascension Providence/MSUCHMFellowship, Hematology and Medical Oncology, 2015 - 2018
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2010 - 2013
King Edward Medical UniversityClass of 2007
Certifications & Licensure
TX State Medical License 2024 - 2026
CA State Medical License 2018 - 2025
MI State Medical License 2012 - 2020
MA State Medical License 2016 - 2016
AR State Medical License 2014 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Pulmonary manifestations during neutrophil engraftment in recipients of allogeneic hematopoietic cell transplantation for myelofibrosis.Salman Otoukesh, Idoroenyi Amanam, Dongyun Yang, Diana Samuels, Amandeep Salhotra
Bone Marrow Transplantation. 2025-09-24 - The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.Jose Tinajero, Kim Nguyen, Dat Ngo, Vaibhav Agrawal, Haoyue Shan
American Journal of Hematology. 2025-09-09 - The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B-cell precursor acute lymphoblastic leukaemia in measurable residual disease-...Jose Tinajero, Dat Ngo, Maria Motta, Vaibhav Agrawal, Paul Koller
British Journal of Haematology. 2025-08-01
Abstracts/Posters
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab OzogamicinShukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabShukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...Shukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









